The treatment of HCC with miR-1247-3p would increase the expression levels of IL-1β, IL-6, and IL-8, thus suggesting the proinflammatory role of miR-1247-3p (Fang et al., 2018). The gene discussed is CXCL8; the disease is hepatocellular carcinoma.